Investigative Urology - Results from #680

Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing May 2, 2016

Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis May 2, 2016

Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2'-deoxycytidine May 2, 2016

Association of AKR1C3 Polymorphisms with Bladder Cancer May 2, 2016

Inhibition of Growth by Combined Treatment with Inhibitors of Lactate Dehydrogenase and either Phenformin or Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase 3 May 2, 2016

Deregulation of seven CpG island-harboring miRNAs in bladder cancer: miR-155 and miR-23b as the most promising oncomiRs May 2, 2016

Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer May 1, 2016

Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer. April 28, 2016

Uroguanylin modulates (Na(+)+K(+))ATPase in a proximal tubule cell line: Interactions among the cGMP/protein kinase G, cAMP/protein kinase a, and mTOR pathways April 28, 2016

The possible role of the tumour necrosis factor polymorphisms and human leucocyte antigens in the development of prostate cancer April 28, 2016

Androgen Receptor Antagonists Suppress Immunotherapy in Prostate Cancer April 28, 2016

Photo-thermal therapy of bladder cancer with Anti-EGFR antibody conjugated gold nanoparticles April 28, 2016

The role of annexin A4 in cancer April 28, 2016

Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2 April 28, 2016

Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats. April 28, 2016

New Therapeutic Target for Prostate Cancer April 28, 2016

The role of glycans in the development and progression of prostate cancer April 28, 2016

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer April 28, 2016

The cross-talk between Wnt/β-Catenin and CIP2A/Plk1 signaling in prostate cancer: promising therapeutic implications. April 28, 2016

Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery April 28, 2016

Page 35 of 346